Expression levels of miRNA 22-5p and miRNA 337-5p in bladder cancer
The Indian Journal of Medical Research · 04.04.2026 · 163 · 290-294
DOI: 10.25259/ijmr_2226_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 04.04.2026. Verfasst von Mehmet Aydin Dagdeviren und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1, Department of Biology, Health Services, Gaziantep University, Gaziantep, Turkey. Hauptthemen laut MEDLINE: MicroRNAs, Urinary Bladder Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression at the post-transcriptional level and play critical roles in tumour development and progression. Bladder cancer requires reliable molecular biomarkers for diagnosis and prognosis; the roles of certain miRNAs remain insufficiently explored. This study aimed to investigate the expression profiles of miR-22-5p and miR-337-5p in bladder cancer and to evaluate their associations with clinicopathological characteristics.
Methods
Paired tumour and adjacent non-tumorous bladder tissue samples were collected from 50 patients undergoing transurethral resection of bladder tumour. Quantitative PCR was performed using RNA U6 as the reference gene. Expression differences were analysed, and correlations with clinicopathological features were assessed.
Results
Both miR-22-5p and miR-337-5p were downregulated in tumour tissues compared to normal tissues. miR-22-5p expression showed a marked reduction in bladder cancer, while miR-337-5p downregulation reached borderline statistical significance. Correlation analyses revealed no association between miR-22-5p expression and clinical variables; however, miR-337-5p expression was significantly correlated with patient age and disease duration. Interpretation and conclusions Altered expression of miR-22-5p and miR-337-5p may contribute to bladder cancer pathogenesis. miR-22-5p appears as a potential tumour suppressor, while miR-337-5p expression is influenced by clinical parameters such as age and disease duration, highlighting their potential roles as prognostic and therapeutic biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1, Department of Biology, Health Services, Gaziantep University, Gaziantep, Turkey.
- 2, Department of Medical Services and Techniques, Health Services, Gaziantep University, Gaziante, Turkey.
- 3, Department of Urology, Gaziantep University Medical Faculty Research Hospital, Gaziantep, Turkey.
Zitieren
APA
Dagdeviren, M. A., Oguzkan, S. B., Ozaslan, M., & Erturhan, M. S. (2026). Expression levels of miRNA 22-5p and miRNA 337-5p in bladder cancer. The Indian Journal of Medical Research, 163, 290-294. https://doi.org/10.25259/ijmr_2226_2025
Vancouver
Dagdeviren MA, Oguzkan SB, Ozaslan M, Erturhan MS. Expression levels of miRNA 22-5p and miRNA 337-5p in bladder cancer. The Indian Journal of Medical Research. 2026;163:290-294. doi:10.25259/ijmr_2226_2025
BibTeX
@article{Dagdeviren2026,
author = {Dagdeviren, Mehmet Aydin and Oguzkan, Sibel Bayil and Ozaslan, Mehmet and Erturhan, Mehmet Sakip},
title = {Expression levels of miRNA 22-5p and miRNA 337-5p in bladder cancer},
journal = {The Indian Journal of Medical Research},
year = {2026},
volume = {163},
pages = {290--294},
doi = {10.25259/ijmr_2226_2025}
}
EUVIMED